Pathophysiology of neurogenic bladder dysfunction

Pediatric Neurogenic Bladder Dysfunction: Diagnosis, Treatment, Long-Term Follow-up

Volumn , Issue , 2006, Pages 33-38

  Nijman, Rien J M ^a   Tekgül, Serdar ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955470514     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-540-30867-9_4     Document Type: Chapter

References (61)

1. Bauer SB. The management of the myelodysplastic child: A paradigm shift. BJU Int 2003; 92: 23-8.
2. Retik AB, Perlmutter AD, Gross RE. Cutaneous ureteroileostomy in children. N Engl J Med 1967; 277:217-22.
3. Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean intermittent self-catheterization in the treatment of urinary tract disease. J Urol 1972;107:458-62.
4. Bauer SB. "fte management of spina bifida from birth onwards. In: Whitaker RH, Woodard JR (eds): Paediatric urology. London, Butterworths, 1985, pp 87-112.
5. Bauer SB. Early evaluation and management of children with spina bifida. In: King LR (ed): Urologic surgery in meonates and young Infants. Philadelphia, Saunders, 1988, pp 252-264.
6. Wilcock AR, Emery JL. Deformities of the renal tract in children with myelomeningocele and hydrocephalus, compared with those children showing no such deformities. Br J Urol 1970;42:152-9.
7. Hunt GM, Whitaker RH. The pattern of congenital renal anomalies associated with neural tube defects. Dev Med Child Neurol 1987; 29:91-5.
8. Tanikaze S, Sugita Y. Cystometric examination for neurogenic bladder of neonates and infants. Hinyokika Kiyo 1991; 37:1403-5.
9. Zoller G, Schoner W, Ringert RH. Pre-and postoperative findings in chldren with tethered spinal cord syndrome. Eur Urol 1991; 19:139-41.
10. Ghoneim GM, Shoukry MS, Hassouna ME. Detrusor properties in myelomeningocele patients: in vitro study. J Urol 1998; 159:2193-6.
11. Zermann DH, Lindner H, Huschke T, Schubert J. Diagnostic value of natural fill cystometry in neurogenic bladder in children. Eur Urol 1997; 32:223-8.
12. Webb RJ, Griffiths CJ, Ramsden PD, Neal DE. Measurement of voiding pressures on ambulatory monitoring: comparison with conventional cystometry. Br J Urol 1990; 65:152-4.
13. Palmer LS, Richards I, Kaplan WE. Age related bladder capacity and bladder capacity growth in children with myelomeningocele. J Urol 1997; 158:1261-4.
14. Agarwal SK, McLorie GA, Grewal D, Joyner BD, Bagli DJ, Khoury AE. Urodynamic correlates or resolution of reflux in meningomyelocele patients. J Urol 1997; 158:580-2.
15. McGuire EJ et al. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 1981; 126:205-9.
16. Sillen U, Hansson E, Hermansson G, Hjalmas, Jacobsson B, Jodal U. Development of the urodynamic pattern in infants with myelomeningocele. Br J Urol 1996; 78: 596-601.
17. Tarcan T, Bauer S, Olmedo E, Koshbin S, Kelly M, Darbey M. Long-term follow-up of newborns with myelodysplasia and normal urodynamic findings: Is follow-up necessary? J Urol 2001; 165:564-7.
18. KasabianNG et al. "fte prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Am J Dis Child 1992; 146:480-7.
19. Wang SC et al. Urethral dilatation in the management of urological complications of myelodysplasia. J Urol 1989; 142:1054-5.
20. Lin-Dyken DC, Wolraich ML, Hawtrey CE, Doja MS. Follow-up of clean intermittent catheterization for children with neurogenic bladders. Urology 1992; 40:525-9.
21. Kaufman AM, Ritchey ML, Roberts AC, Rudy DC, McGuire EJ. Decreased bladder compliance in patients with myelomeningocele treated with radiological observation. J Urol 1996; 156:2031-3.
22. Wu HY, Baskin LS, Kogan BA. Neurogenic bladder dysfunction due to myelomeningocele: neonatal versus childhood treatment. J Urol 1997; 157:2295-7.
23. Kaefer M, Pabby A, Kelly M, Darbey M, Bauer SB. Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomeningocele. J Urol 1999; 162:1068-71.
24. Van Gool JD, Dik P, de Jong TP. Bladder-sphincter dysfunction in myelomeningocele. Eur J Pediatr 2001; 160:414-20.
25. Bauer SB. The argument for early assessment and treatment of infants with spinabifida. Dial Pediatr Urol 2000; 23:2-3.
26. Park JM. Early reduction of mechanical load of the bladder improves compliance: experimental and clinical observations. Dial Pediatr Urol 2000; 23:6-7.
27. Lindehall B, Moller A, Hjalmas K, Jodal U. Long-term intermittent catheterization: The experience of teenagers and young adults with myelomeningocele. J Urol 1994; 152:187-9.
28. Joseph DB, Bauer SB, Colodny AH, et al. Clean intermittent catheterization in infants with neurogenic bladder. Pediatrics 1989; 84:78-83.
29. Park JM. Early reduction of mechanical load of the bladder improves compliance: experimental and clinical observations. Dial Pediatr Urol 2000; 23:6-7.
30. Kasabian NG, Bauer SB, Dyro FM, et al. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Am J Dis Child 1992; 146:840-4.
31. Baskin LS, Kogan BA, Benard F. Treatment of infants with neurogenic bladder dysfunction using anticholinergic drugs and intermittent catheterization. Br J Urol 1990; 66:532-4.
32. Connor JP, Betrus G, Fleming P, Perlmutter AD, Reitelman C. Early cystometrograms canpredictthe response to intravesical instillation of oxybutynin chloride in myelomeningocele patients. J Urol 1994; 151:1045-7.
33. Goessl C, Knispel HH, Fiedler U, Harle B, Steffen-Wilke K, Miller K. Urodynamic effects of oral oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia. Urology 1998; 51:94-8.
34. Haferkamp A, Staehler G, Gerner HJ, Dorsam J. Dosage escalation of intravesical oxybutynin in the treatment of neurogenic bladder patients. Spinal Cord 2000; 38:250-4.
35. Ferrara P, DAleo CM, Tarquini E, Salvatore S, Salvaggio E. Side effects of oral or intravesical oxybutynin chloride in children with spina bifida. BJU Int 2001; 87:674-8.
36. Lopez Pereira P, Miguelez C, Caffarati J, Estornell F, Anguera AJ. Trospium chloride for the treatment of detrusor instability in children. Urology 2003; 170:1978-81.
37. Austin PF, Homsy YL, Masel JL, Cain MP, Casale AJ, Rink RC. Alpha-adrenergic blockade in children with neuropathic and non-neuropathic voiding dysfunction. J Urol 1999; 162:1064-7.
38. Lapointe SP, Wang B, Kennedy WA, Shortliffe LM. tte effects of intravesical lidocaine on bladder dynamics of children with myelomeningocele. J Urol 2001; 165:2380-2.
39. Smith CP, Somogyi GT, Chancellor MB. Emerging role of botulinum toxin in the treatment of neurogenic and non-neurogenic voiding dysfunction. Curr Urol Rep 2002; 3: 3827.
40. Leippold T, Reitz A, Schurch B. Botulinum toxin as a new therapy option for voiding disorders: current state of eart. Eur Urol 2003;44: 165-74.
41. Schulte-Baukloh H, Knispel HH, Michael T. Botulinum-A toxin in the treatment of neurogenic bladder in children. Pediatrics 2002; 110:420-1.
42. Lusuardi L, Nader A, Koen M, Schrey A, Schindler M, Riccabona M. Minimally invasive, safe treatment of the neurogenic bladder with botulinum-A-toxin in children with myelomeningocele. Aktuelle Urol 2004; 35:49-53.
43. Younoszai MK: Stooling problems in patients with myelomeningocele. South Med J 1992; 85:718.
44. Squire R, Kiely EM, Carr B, et al. The clinical application of the Malone antegrade colon colonic enema. J Pediatr Surg 1993; 28:1012-15.
45. Whitehead WE, Wald A, Norton NJ. Treatment options for fecal incontinence. Dis Colon Rectum 2001; 44:131-42.
46. Krogh K, Kvitzau B, Jorgensen TM, Laurberg S. Treatment of anal incontinence and constipation with transanal irrigation. Ugeskr Laeger 1999; 161:253-6.
47. Van Savege JG, Yohannes P. Laparoscopic antegrade continence enema in situ appendix procedure for refractory constipation and overflow fecal incontinence in children with spinabifida. J Urol 2000; 164:1084-7.
48. Aksnes G, Diseth TH, Helseth A, Edwin B, Stange M, Aafos G, Emblem R. Appendicostomy for antegrade enemas: effects on somatic and psychosocial functioning in children with myelomeningocele. Pediatrics 2002; 109:484-9.
49. Loening-Baucke V, Deach L, Wolraich M. Biofeedback training for patients with myelomeningocele and fecal incontinence. Dev Med Child Neurol 1988; 30:781-6.
50. Marshall DF, Boston VE. Altered bladder and bowel function following cutaneous electrical field stimulation in children with spina bifida: interim results of a randomized double-blind placebo-controlled trial. Eur J Pediatr Surg 1997; 7:4143.
51. Hansson S, Caugant D, Jodal U, Svanborg-Eden C. Untreated asymptomatic bacteriuria in girls: I. Stability of urinary isolates. Br Med J 1989; 298:853-5.
52. Hansson S, Jodal U, Lincoln K, Svanborg-Eden C. Untreated asymptomatic bacteriuria in girls: II. Effect of phenoxymethylpenicillin and erythromycin given for intercurrent infections. Br Med J 1989; 298:856-9.
53. Hansson S, Jodal U, Noren L, Bjure J. Untreated bacteriuria in asymptomatic girls with renal scarring. Pediatrics 1989; 84:964-8.
54. Johnson HW, Anderson JD, Chambers GK, Arnold WJ, Irwin WJ, Brinton JR. A short-term study of nitrofurantoin prophylaxis in children managed with clean intermittent catheterization. Pediatrics 1994; 93:752-5.
55. Schlager TA, Anderson S, Trudell J, hendley JO. Nitrofurantoin prophylaxis for bacteriuria and urinary tract infection in children with neurogenic bladder on intermittent catheterization. J Pediatr 1998; 132:704-8.
56. Naglo AS. Continence training of children with neurogenic bladder and hyperactivity of the detrusor. Scan J Urol Nephrol 1982; 16:211-17.
57. Austin PF, Westney OL, Leng WW, McGuire EJ, Ritchey ML. Advantages of rectus fascial slings for urinary incontinence in childrenwith neuropathic bladder. J Urol 2001; 165: 2369-71.
58. Guys JM, Fakhro A, Louis-Borrione C, Prost J, Hautier A. Endoscopic treatment of urinary incontinence: long-term evaluation of the results. J Urol 2001; 165: 2389-91.
59. Kassouf W, Capolicchio G, Bernardinucci G, Corcos J. Collagen injection for treatment of urinary incontinence in children. J Urol 2001; 165: 1666-8.
60. Kryger JV, Leverson G, Gonzalez R. Long-term results of artificial urinary sphincters in children are independent of age at implantation. J Urol 2001; 165: 2377-79.
61. Holmes NM, Kogan BA, Baskin LS. Placement of artificial urinary sphincter in children and simultaneous gastrocystoplasty. J Urol 2001; 165: 2366-68.